Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Injection site bruising; Injection site pain; Nausea; This is a spontaneous report from a contactable consumer received from the Regulatory Authority; the Regulatory Authority report number is GB-MHRA-WEBCOVID-202106141814586390-HDSB4 and the Safety Report Unique Identifier is GB-MHRA-ADR 25472364. An 18-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 04Jun2021 (batch/lot number was not reported) at 18 years old, as DOSE 1, SINGLE for COVID-19 immunization. The patient''s medical history included lactation decreased from an unknown date. The patient was not enrolled in clinical trial. Patient was not currently breastfeeding. Patient has not had symptoms associated with COVID-19. Concomitant medications were not reported. The patient experienced nausea on 04Jun2021, injection site pain on 05Jun2021, and injection site bruising on 06Jun2021. The patient recovered from the event nausea on 05Jun2021, from the event injection site pain on 08Jun2021, and from the event injection site bruising on 12Jun2021. The events were reported as medically significant. The patient has not tested positive for COVID-19 since having the vaccine; patient tested no - negative for COVID-19 virus test on an unspecified date. No follow-up attempts are possible; information about the batch/lot number cannot be obtained.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166